• <nav id="cpgn9"></nav>

  • <sub id="cpgn9"><table id="cpgn9"><div id="cpgn9"></div></table></sub>
  • DSM at a glance

    Overview of our business & performance

    A broad, global health and nutrition business

    DSM is a global purpose-led, science-based company founded in 1902 and listed on Euronext Amsterdam. We are a leader in health, nutrition and bioscience which, through our products and solutions,?aims to address some of the world’s biggest challenges whilst creating profitable growth in order to simultaneously deliver economic, environmental and societal value for all.

    2022 key data

    Group

    €8,390m

    Net sales

    €7,269 in 2021

    €1,395m

    Adjusted EBITDA

    €1,379 in 2021

    16.6%

    Adjusted EBITDA margin

    19.0% in 2021

    Health, Nutrition & Bioscience

    €8,319m

    Net sales

    €7,166 in 2021

    €1,490m

    Adjusted EBITDA

    €1,467 in 2021

    17.9%

    Adjusted EBITDA margin

    20.5% in 2021

    People

    0.28

    Frequency Index of Recordable Injuries

    0.22 in 2021

    77%

    Employee Engagement Index

    77% in 2021

    26%

    Female executives

    23% in 2021

    Planet

    35%

    Absolute reduction

    Scope 1 + 2 GHG emissions (2016 baseline)

    ~26%

    Structural improvement

    Scope 1 + 2 GHG emissions (2016 baseline)

    17%

    Intensity improvement

    Scope 3 GHG emissions (2016 baseline)

    Profit

    ↑1%

    Adjusted EBITDA

    continuing operations vs. 2021

    €310m

    Adjusted net operating free cash flow

    €555m

    Net profit from continuing operations

    Latest financial & regulatory news

    • DSM - delivery of shares

      28 Apr 2023

      Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.

    • DSM - delivery of shares

      26 Apr 2023

      Following the Offering Circular published on 22 November 2022, DSM and DSM-Firmenich are required to announce transactions in relation to the ordinary shares in their respective share capital in accordance with the Dutch public offer rules.

    Managing Board

    Geraldine Matchett, Co-CEO

    Geraldine Matchett is Co-Chief Executive Officer, Chief Financial Officer and Member of the Managing Board. She was appointed as Co-CEO on 15 February 2020 and joined DSM’s Managing Board in 2014.?

    Dimitri de Vreeze, Co-CEO

    Dimitri de Vreeze is Co-Chief Executive Officer, Chief Operating Officer and Member of the Managing Board. He was appointed as Co-CEO on 15 February 2020 and joined DSM’s Managing Board in 2013.?

    Read more

    • Factbooks

      Factbooks

      DSM's Factbook provides investors and analysts with an introduction to the company and our key individual businesses.

    最近中文字幕高清字幕在线视频,久久九色综合九色99伊人,久久精品中文字幕第一页,久久精品国产清高在天天线,久久狠狠色噜噜狠狠狠狠97,久久国产亚洲精品麻豆,久久福利电影 昌吉市| 江津市| 抚顺县| 巴彦淖尔市| 个旧市| 大足县| 菏泽市| 赤水市| 静乐县| 靖宇县| 蒙城县| 江西省| 福清市| 洪泽县| 乌拉特后旗| 安徽省| 漾濞| 麟游县| 富平县| 六安市| 五华县| 河曲县| 平果县| 汪清县| 定远县| 湖口县| 常熟市| 友谊县| 凤城市| 太谷县| 弥渡县| 龙山县| 通化市| 米林县| 侯马市| 重庆市| 华坪县| 通辽市| 青田县| 五河县| 婺源县| http://444 http://444 http://444 http://444 http://444 http://444